Publications

Pneumococcal Conjugate Vaccine (PCV7) Effect on Antibiograms: Serotype and Susceptibility (S) Rate Changes in the SENTRY Antimicrobial Surveillance Program (USA), Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes, Lead author: Mera RM, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Carbapenem Resistances Among P. aeruginosa Isolated in an USA Medical Center: Report of Osteomyelitis Caused by an IMP-15 Producing Strain, Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Limiting Fluoroquinolone (FQ) Resistance in S. aureus in an In Vitro Model Using Optimized Treatment Intensity and Duration, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Comparison of the Probability of Target Attainment (PTA) Between Ceftriaxone (CRO) and Cefepime (CEP) in the Cerebrospinal Fluid (CSF) and Plasma Against Streptococcus pneumoniae, Lead author: Lodise TP, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Use of Pharmacodynamic Endpoints for the Evaluation of Levofloxacin for the Treatment of Acute Maxillary Sinusitis, Lead author: Drusano GL, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Coexistence of Epidemic and Allodemic Ocurrences in bla VIM-1 Metallo-B-Lactamase Producing Enterobacteriaceae in a Spanish University Hospital, Lead author: Tato M, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Emergence of VIM-1 in Proteus mirabilis and Citrobacter koseri Isolated from European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Evolutionary Trends in Antimicrobial Resistances (R) in E. faecium (EFM) Bacteremia: Report from the SENTRY Antimicrobial Surveillance Program (1997-2005), Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Carbapenem-Resistance Mechanisms Among Acinetobacter Spp. Hospitalised Patients in the SENTRY Asia-Pacific Region, Lead author: Bell JM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular Characterization of Rarely Isolated Garenoxacin-Resistant Streptococcus pneumoniae collected from the SENTRY Antimicrobial Surveillance Program (1999-2005), Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

hVISAs are Common Among Vancomycin Susceptible Methicillin-Resistant Staphylococcus aureus (MRSA); Report from SENTRY Asia-Pacific Region, Lead author: Bell JM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Eight-Year Trends in Carbapenem Resistance Rates in the MYSTIC Programme (USA; 1999-2006), Lead author: Rhomberg PR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Geographic Variations in the Activity of Doripenem and Other Broad-Spectrum Agents: Results from an International Surveillance Program (2003-2005), Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp. vs. Daptomycin, Lead author: Miskov AM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Re-Evaluation of Clinical and Laboratory Standards Institute (CLSI) Disk Diffusion Breakpoints for Tetracycline and Doxycycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Recommended Ulifloxacin MIC Quality Control Ranges Using a CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

An Assessment of the Sensititre Automated/Manual Susceptibility Plate in Detection of Vancomycin Non-Susceptible Staphylococcus spp., Lead author: Killian SB, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Vancomycin Hetero-resistance has a Small but Significant Effect on the Daptomycin Minimum Inhibitory Concentration of Staphylococcus aureus, Lead author: Bell JM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Spectrum and Potency of Ceftobiprole Tested Against Staphylococci and Streptococci Recovered from Patients in Latin America (2003-2005), Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Ceftobiprole Tested Against a Recent Collection of North American Pseudomonas aeruginosa, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Evaluation of the Bactericidal Activity of the Novel Cephalosporin Ceftaroline (PPI-0903M) Compared to Ceftriaxone against Streptococcus pneumoniae, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Doripenem Tested Against an International Collection of ESBL- and AmpC-Producing Enterobacteriaceae, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activities of Doripenem and Other Carbapenems Tested Against Pseudomonas aeruginosa, Other Non-Fermentative Bacilli and Aeromonas spp., Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Daptomycin in Combination with Gentamicin against Contemporary Clinical Isolates of Staphylococcus aureus and Enterococci, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In vitro Activity of Dalbavancin Susceptibility Tested Against Staphylococcus spp. and &#223-haemolytic Streptococcus spp. isolated in USA Medical Centers, Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Tigecycline (TIG) Tested Against Recent Acinetobacter spp. Isolates in North American (NA) Hospitals, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Tigecycline Tested against Vancomycin-Resistant Enterococcus faecium Isolated in North America (NA) and Europe (EU), Including Clonal Complex-17 (CC-17) Strains, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Evaluation of Colistin Alone or in Combination with Antimicrobial Agents Against Clinical Isolates of Carbapenem-Resistant P. aeruginosa (CR-PSA), Lead author: Chin JN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Longitudinal Evaluation of Linezolid Activity: Results from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Surveillance Program (2002-2005), Lead author: Ross JE, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Omiganan Pentahydrochloride Tested Against Vancomycin (VAN) Tolerant, Intermediate (VISA and hVISA) and Resistant (VRSA) S. aureus, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In vitro Activity of a 2′-Substituted-6-alkylidenepenicillin Sulfone (LN-1-255) as a &#223-Lactamase Inhibitor, Lead author: Buynak JD, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Spectrum and Activity of 2′-Substituted-6-alkylidenepenicillin Sulfone/&#223-lactam Combinations Screened Against Resistant Gram-Negative Bacilli, Lead author: Buynak JD, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Potency and Spectrum of DC-159a Tested Against More Than 800 Recent Clinical Isolates, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

DC-159a, a Novel Oral Quinolone, Activity Tested Against Community-Acquired Respiratory Tract (CA-RTI) Pathogens, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Comparative In Vitro Activity of DC-159a, a New Oral Fluoroquinolone, Against Viridans Streptococci, Lead author: Smith K, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Nine Developmental Cationic Steroid Compounds (Ceragenins) Against Clinical Isolates of Clostridium difficile, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of DX-619 Compared to Other Agents against Viridans Streptococci, Lead author: Smith K, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Pneumococcal Conjugate Vaccine Effect on S. pneumoniae Serotype Carriage and Multidrug-Resistance in the United States, Lead author: Mera RM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline (TIG) Tested Against Serine Carbapenemase-Producing Enterobacteriaceae Isolated in the United States, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular and Epidemiologic Characterization of Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Isolated from North American Medical Centers: Report from The SENTRY Program (2000- 2004), Lead author: Deshpande LM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular Characterization of S. aureus (SA) Isolates from a Contemporary (2005) Clinical Trial of Uncomplicated Skin and Skin Structure Infections (uSSSI), Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline against Community-Acquired Methicillin-Resistant S. aureus (CA-MRSA) Isolated in North American Medical Centers, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Time to Sign and Symptom (S&S) Resolution May Not Differ Between Bacterially and Non-Bacterially Infected Patients with Acute Maxillary Sinusitis (AMS), Lead author: Ambrose PG, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Surrogate Glycopeptide Testing Used to Predict Susceptibility to Dalbavancin: A Novel Glycolipopeptide, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Antimicrobial Activity of Daptomycin Tested Against Staphylococcus aureus and Enterococcus spp. Clinical Strains Isolated in European Medical Centers (2002-2005), Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Tigecycline Activity Tested Against Gram-positive Cocci and Enterobacteriaceae Collected in Europe, North America and Latin America, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Activity of Meclocycline Sulfosalicylate Tested Against Oral Pathogens, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Regional Differences in Activity of Tigecycline Tested Against Acinetobacter spp.: Results from a Global Surveillance Programme (2003-2005), Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Tigecycline Activity Against Staphylococcus aureus, Including Vancomycin-Intermediate and -Resistant Isolates, Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal